Sat.May 25, 2024 - Fri.May 31, 2024

article thumbnail

How to Get Into Medical Device Sales: Ultimate Career Guide

David Bagga

How to Get Into Medical Device Sales: Ultimate Career Guide Home Blog How to Get Into Medical Device Sales: Ultimate Career Guide How to Get Into Medical Device Sales: Ultimate Career Guide If you are new to medical device sales and interested in getting a job in this field, here are some essential tips that […] The post How to Get Into Medical Device Sales: Ultimate Career Guide appeared first on.

Sales 130
article thumbnail

Takeda, amid restructuring campaign, plots 641 layoffs at two Massachusetts sites

Fierce Pharma

A recently announced $900 million restructuring drive is already making waves at Takeda, wi | From early July to March 2025, the Japanese drugmaker will cut 495 staffers at its Cambridge location and 146 in Lexington, Massachusetts. Takeda is the largest life sciences employer in the state.

344
344
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

COVID-19 vaccinations now ‘alarmingly low’ in Europe

pharmaphorum

COVID-19 vaccination rates have fallen precipitously in Europe and should be ramped up this autumn so they are at least in line with influenza vaccine uptake.

144
144
article thumbnail

Mental Health Inequities Could Cost $1.3 Trillion in 2040. How Can the Industry Prevent This?

MedCity News

Mental health inequities are costing the U.S. $477.5 billion annually. This could rise to $1.3 trillion in 2040 if left unaddressed. The post Mental Health Inequities Could Cost $1.3 Trillion in 2040. How Can the Industry Prevent This? appeared first on MedCity News.

Medical 135
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

How to Get Medical Device Sales Jobs with No Experience?

David Bagga

How to Get Medical Device Sales Jobs with No Experience? Home Blog How to Get Medical Device Sales Jobs with No Experience? How to Get Medical Device Sales Jobs with No Experience? Medical device sales become one of the best career options today. More and more people want to crack medical device sales jobs and […] The post How to Get Medical Device Sales Jobs with No Experience?

Sales 130
article thumbnail

BioNTech, flush with $145M from CEPI, looks to expand mRNA vaccine production in Africa

Fierce Pharma

As various efforts to produce next-generation vaccines in Africa are being carried forward by the likes of the World Health Organization (WHO) and the Bill & Melinda Gates Foundation, BioNTech | Under an expansion of the partners’ existing deal, the Coalition for Epidemic Preparedness Innovations (CEPI) is committing up to $145 million to bolster BioNTech’s efforts to establish vaccine R&D and manufacturing capabilities at the German company’s facility in Kigali, Rwanda.

More Trending

article thumbnail

J.D. Power: Customer Experience Gap Grows Among Commercial Health Plans

MedCity News

A new J.D. Power ranking of commercial health plans found a major difference in customer satisfaction between the top and bottom-ranked health plans. The post J.D. Power: Customer Experience Gap Grows Among Commercial Health Plans appeared first on MedCity News.

131
131
article thumbnail

How to Become A Medical Device Sales Rep in 2024?

David Bagga

Medical device sales is a burgeoning market, with jobs that have an extremely high earning potential. In 2018, the average base salary of a medical sales representative was $92,698 How to Become A Medical Device Sales Rep in 2024? Home Blog How to Become A Medical Device Sales Rep in 2024? How to Become A […] The post How to Become A Medical Device Sales Rep in 2024?

Sales 130
article thumbnail

CSL Seqirus scores 4th award from US government for bird flu pandemic preparedness

Fierce Pharma

The United States Department of Health and Human Services has expanded its avian flu pandemic preparedness partnership with CSL Seqirus, lining up the vaccine specialist to

article thumbnail

US Congress passes bill to end Parkinson’s disease

pharmaphorum

The US Congress has passed the first-ever federal bill dedicated to ending Parkinson’s disease, modelled on similar legislation for Alzheimer’s enacted in 2011

119
119
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

With M&A Deal, Click Therapeutics’ Digital Prospects in Metabolic Disease Get Better

MedCity News

Click Therapeutics is acquiring the assets of Better Therapeutics two months after that digital therapeutics developer announced it would lay off all employees and shut down. Better’s main asset is AspyreRx, an FDA-authorized mobile app for type 2 diabetes. The post With M&A Deal, Click Therapeutics’ Digital Prospects in Metabolic Disease Get Better appeared first on MedCity News.

article thumbnail

How to Become A Medical Sales Rep With No Experience 2024?

David Bagga

Medical device sales is a burgeoning market, with jobs that have an extremely high earning potential. In 2018, the average base salary of a medical sales representative was $92,698 How to Become A Medical Sales Rep With No Experience 2024? Home Blog How to Become A Medical Sales Rep With No Experience 2024? How to […] The post How to Become A Medical Sales Rep With No Experience 2024?

article thumbnail

Gilead's Trodelvy suffers double whammy as failed bladder cancer trial raises flag over early deaths

Fierce Pharma

In the span of half a year, Gilead Sciences' Trodelvy has flopped a second phase 3 trial. | Following a high-profile lung cancer setback in January, Gilead said Thursday that Trodelvy also failed to move the needle in a bladder cancer study. The flop threatens the ADC's accelerated approval in the tumor type.

327
327
article thumbnail

Digital therapeutics firm Akili agrees $34 million takeover

pharmaphorum

More consolidation in the digital health sector as Akili agrees a $34m takeover by Virtual Therapeutics, returning to private hands.

119
119
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

ONC Chief: New AI Transparency Rule Should Drive Higher Quality Tools & More AI Adoption

MedCity News

Micky Tripathi, head of The Office of the National Coordinator for Health Information Technology (ONC), thinks his office’s recent rule on AI transparency will spur greater adoption of AI tools in healthcare, as well as potentially drive higher quality AI-based products. The post ONC Chief: New AI Transparency Rule Should Drive Higher Quality Tools & More AI Adoption appeared first on MedCity News.

article thumbnail

How Much Do Medical Device Sales Reps Make in 2024?

David Bagga

How Much Do Medical Device Sales Reps Make in 2024? Home Blog How Much Do Medical Device Sales Reps Make in 2024? How Much Do Medical Device Sales Reps Make in 2024? When looking for a medical device sales rep job, a common question is, ‘How much does a medical device sales rep earn? It’s […] The post How Much Do Medical Device Sales Reps Make in 2024?

Sales 130
article thumbnail

Moderna, with FDA nod for RSV vaccine, grows reach beyond the pandemic

Fierce Pharma

With the FDA nod, Moderna's RSV vaccine becomes the company's second product to secure the FDA's backing.

FDA 325
article thumbnail

Working for a mature form of genomic medicines

pharmaphorum

In a new episode of the pharmaphorum podcast, Rahul Kakkar, CEO of gene editing company Tome, speaks with web editor Nicole Raleigh about programmable genomic integration (PGI) technology.

Medicine 118
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Protect Personalized, Independent Kidney Care

MedCity News

A pending CMS policy could cause havoc for independent kidney care facilities and patients who need life-sustaining treatments. The post Protect Personalized, Independent Kidney Care appeared first on MedCity News.

Patients 126
article thumbnail

As Senate’s gaze lands on patents, a former US PTO chief calls the effort a ‘broad misunderstanding’

PharmaVoice

To lower drug prices, lawmakers are turning to the drug patent system to outlaw some common practices — but a former patent agency director says it’s the wrong way to go.

111
111
article thumbnail

ASCO: In surprise, J&J's injectable Rybrevant extends lung cancer patients' lives versus intravenous version

Fierce Pharma

When companies introduce an injectable version of an intravenously infused drug, better convenience with comparable efficacy is typically the goal. | When companies introduce an injectable version of an intravenously infused drug, better convenience with comparable efficacy is typically the goal. But to Johnson & Johnson’s surprise, a subcutaneous formulation of its lung cancer med Rybrevant proved to work better than the original infusion.

Patients 324
article thumbnail

Ex-Jazz, Sunesis exec Swisher takes over at NodThera

pharmaphorum

NLRP3-focused biotech NodThera has named former Jazz Pharma and Sunesis executive Dan Swisher as its new CEO.

Pharma 115
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

Making Access to AI-enabled Medical Devices Equitable for All

MedCity News

If Medicare acts, the potential of AI-enabled technologies to improve healthcare outcomes for patients, regardless of their geographic location or socioeconomic status, will be closer to being fully realized. The post Making Access to AI-enabled Medical Devices Equitable for All appeared first on MedCity News.

Medical 126
article thumbnail

Improving stem cell transplantation success in high-risk blood cancers

European Pharmaceutical Review

Repurposing cyclophosphamide may enable more patients with high-risk blood cancers to receive transplanted stem cells from unrelated, partially matched donors, new research suggests. These new findings, which are part of an ongoing Phase II study , will be presented at the 2024 American Society of Clinical Oncology (ASCO) meeting and the European Hematology Association ( Abstract #6503 ).

article thumbnail

Data breach at pharma partner Cencora puts sensitive patient information at risk

Fierce Pharma

A data breach at drug distributor Cencora has left sensitive information vulnerable, with patients on medicines from a dozen drugmakers potentially affected. | The potentially compromised data included patient information such as names and addresses, Cencora disclosed in letters to patients who may have been affected.

Patients 325
article thumbnail

Update: MSD confirms $3bn takeover of EyeBio

pharmaphorum

MSD has confirmed a $3 billion takeover deal for ophthalmology biotech EyeBio and its drug candidate for diabetic macular oedema (DME) and neovascular age-related macular degeneration (AMD).

114
114
article thumbnail

How to Stay Competitive in the Evolving State of Martech

Marketing technology is essential for B2B marketers to stay competitive in a rapidly changing digital landscape — and with 53% of marketers experiencing legacy technology issues and limitations, they’re researching innovations to expand and refine their technology stacks. To help practitioners keep up with the rapidly evolving martech landscape, this special report will discuss: How practitioners are integrating technologies and systems to encourage information-sharing between departments and pr

article thumbnail

FDA Approves Moderna RSV Vaccine, an mRNA Alternative to GSK and Pfizer Products

MedCity News

Moderna’s mResvia is now the third FDA-approved RSV vaccine and the first one based on mRNA technology. It will compete for market share against RSV shots from GSK and Pfizer that won their FDA nods last year. The post FDA Approves Moderna RSV Vaccine, an mRNA Alternative to GSK and Pfizer Products appeared first on MedCity News.

FDA 125
article thumbnail

Can robots break the cell therapy bottleneck?

PharmaVoice

A partnership between the cell therapy delivery specialist Portal Biotechnologies and precision robotics maker Multiply Labs could bring the manufacturing bottleneck under control, the CEOs said.

article thumbnail

Bristol Myers secures another FDA go-ahead for Breyanzi, this time in mantle cell lymphoma

Fierce Pharma

In the years since gaining an initial FDA approval for Breyanzi, Bristol Myers Squibb has worked hard to expand the reach of its cell therapy. | In the years since gaining an initial FDA approval for Breyanzi, Bristol Myers Squibb has worked hard to expand the reach of its cell therapy. For the third time in as many months, those efforts have yielded a label expansion at the FDA.

FDA 323
article thumbnail

Trial readout sets up filings for Insmed bronchiectasis drug

pharmaphorum

Shares in Insmed double as phase 3 trial sets up filings for brensocatib, aiming to become the first approved drug for bronchiectasis

113
113
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time